Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 5540 of 6351
-
Can a simple drug cut blood loss in spine surgery?
Disease control Recruiting nowAs tranexamic acid (TXA) becomes more prevalent, all patients are receiving the same dose and method of delivery regardless of their pre-operative risk of transfusion. Therefore, the aim of the study is to determine whether or not repeated dosing of oral or different method of de…
Early phase 1 • Sponsor: Rush University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Bile acid hope for pouchitis patients fizzles in early study
Disease control Stopped earlyThe cause of Inflammatory bowel disease (IBD) is unknown, but intestinal bacteria-involved in the production of molecules that impact health-are widely accepted to play a key role. A significant proportion of IBD patients with pouches (surgically created rectums after the disease…
Phase 2/3 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Japanese hemophilia b patients monitored on refixia – no surprises found
Disease control CompletedThe participants are invited to take part in this study because they have Haemophilia B. The purpose of this study is to assess the safety and effectiveness of Refixia® about long-term routine use in patients with Haemophilia B. The participants will get Refixia® as prescribed to…
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can MRI beat ultrasound for heart valve diagnosis?
Diagnosis Recruiting nowThe purpose of the study is to compare the various 2D and 3D methods of valvular heart disease quantification (Doppler, PISA, VCA, volumetric method) and strain with cardiac magnetic resonance (CMR) measurements of left and right ventricular systolic function strain and myocardia…
Sponsor: The Cleveland Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
Experimental drug losmapimod tested in rare muscle disease – early hopes, but trial cut short
Disease control Stopped earlyThis clinical trial is a study to evaluate the safety, tolerability, and changes in biomarker and clinical outcome assessments of Losmapimod for patients with Facioscapulohumeral Muscular Dystrophy 1 (FSHD1) with an open-label extension.
Phase 2 • Sponsor: Fulcrum Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can scans and blood predict brain fog after radiation?
Knowledge-focused Stopped earlyThis study determines whether non-invasive evaluation using repeated magnetic resonance imaging (MRI) scans and repeated blood biomarker measurements can be used to predict changes in a person's mental functions that result from radiation exposure to the brain. This study may let…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Liberia's HIV epidemic under the microscope: major study completed
Knowledge-focused CompletedBackground: There are many people living with human immunodeficiency virus (HIV) infection in Liberia. Most experts consider HIV an epidemic there. Researchers want to collect health data from Liberians with HIV over several years. This may help HIV prevention and treatment prog…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Heart attack patients may get safer blood thinners tailored to their genes
Disease control Stopped earlyIn patients after myocardial infarction (MI) (heart attacks) and treated with percutaneous coronary intervention (PCI), the current standard is dual antiplatelet therapy (DAPT), with aspirin and a P2Y12 receptor inhibitor, for 1 year of treatment. At 1 year, there are several opt…
Phase 4 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can Ultra-Low nicotine cigarettes help pregnant smokers cut down?
Disease control CompletedStudy 2 will evaluate the effects of extended exposure to cigarettes with varying levels of nicotine in pregnant smokers who have less than an Associate's degree. This study will be limited to two conditions: usual brand vs. 0.4 mg nicotine/g tobacco. After a baseline period in w…
Phase 1/2 • Sponsor: University of Vermont • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Pregnancy weight patterns linked to baby fat at birth
Knowledge-focused By invitation onlyEarly life influences (including the intrauterine environment, birth weight, and early postnatal growth) shape subsequent weight trajectories and future chronic disease risk. The MINT study will evaluate whether maternal fat mass changes are associated with specific maternal weig…
Sponsor: University of Texas at Austin • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Experimental combo targets Hard-to-Treat head and neck cancers
Disease control CompletedThe purpose of this study is to see if the IRX-2 regimen and Durvalumab, will have a tolerable safety profile and will increase the intratumoral immune profile compared with the pretreatment tumors.
Phase 1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New study tracks COPD patients on trimbow: better breathing or just better compliance?
Symptom relief CompletedThe mean objectives are to evaluate the impact of BDP/FF/G fixed combination on health-status and adherence
Sponsor: Chiesi Italia • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Exercise may ease pain in lung cancer survivors, small study hopes
Symptom relief OngoingExercise rehabilitation has the potential as a non-pharmacological approach to reduce persistent neuropathic pain in Veterans with lung cancer. By examining the effects of exercise training in Veteran cancer survivors with NSCLC, there is the potential to revolutionize care for a…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Promising c. diff drug fails to prove benefit in small, halted trial
Disease control Stopped earlyA new medication, Bezlotoxumab, has been approved for treatment of recurrent Clostridium difficile diarrhea by the U.S. Food and Drug Administration. The way this new medication works, is by binding the toxin produced by C. difficile bacteria and preventing damage to the large bo…
Phase 4 • Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Ketamine's brain impact revealed in small stanford study
Knowledge-focused CompletedThis study is a biomarker study designed to characterize how ketamine impacts the reward circuits of the human brain.
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Scientists hunt for genes to reverse aging body clock
Knowledge-focused PausedThe goal is to address the mechanisms that account for alteration of circadian rhythms with age. As the blood of aged individuals can produce this alteration, the investigators propose to use such blood samples to "age" circadian rhythms in cultured cells. The investigators will …
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Could a geriatric check before knee or hip surgery boost recovery and cut costs?
Knowledge-focused CompletedThe objective of this randomized control trial is to investigate effects and cost effectiveness of interprofessional preoperative assessment among older knee or hip arthroplasty patients. The main hypothesis is that preoperative assessment and optimization have a positive impact …
Sponsor: University of Eastern Finland • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Mayo clinic study aims to define normal vaccine reactions in kids
Knowledge-focused By invitation onlyThe purpose of this research is to understand the normal healthy response to immunological challenge by measuring circulating cytokine and chemokine levels before and after vaccinations in healthy children. These data will define a range of normal responses that can be used to he…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Can a structured support program ease the first year of juvenile arthritis?
Symptom relief CompletedChildren and parents often experience uncertainty and stress when juvenile idiopathic arthritis (JIA) is first diagnosed, which creates a need for structured support. Juvenile Idiopathic Support Program (JASP-1) provide patient-and family centered support during the first year af…
Sponsor: Region Stockholm • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Promising cancer drug falls short in rare tumor trial
Disease control Stopped earlyThe purpose of this study is to test the safety and efficacy of drug, TAS-102 (trifluridine/tipiracil), in patients with extrapulmonary (outside the lung) high-grade neuroendocrine cancer. TAS-102 demonstrated improved survival and tolerability in patients with colorectal cancer …
Phase 2 • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC